ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation

Marcus Borenäs(University of Gothenburg), Ruth H. Palmer(University of Gothenburg)
The EMBO Journal
January 7, 2021
Cited by 62


Related Papers